FILLDERM

Serial Number 79341039
Registration 7203922
700

Registration Progress

Application Filed
Apr 12, 2022
Under Examination
Approved for Publication
Aug 15, 2023
Published for Opposition
Aug 15, 2023
Registered
Oct 31, 2023

Trademark Image

FILLDERM

Basic Information

Serial Number
79341039
Registration Number
7203922
Filing Date
April 12, 2022
Registration Date
October 31, 2023
Published for Opposition
August 15, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 31, 2023
Registration
Registered
Classes
005

Rights Holder

DATAZI PHARMA LTD

98
Address
Petrou Iliadi, 5,
CHLOE RESIDENCE, Flat/Office 101, Strovolos CY-2015 Nicosia
CY

Ownership History

DATAZI PHARMA LTD

Original Applicant
99
CY

DATAZI PHARMA LTD

New Owner Before Publication #1
99
CY

DATAZI PHARMA LTD

Owner at Publication
99
CY

DATAZI PHARMA LTD

Original Registrant
99
CY

DATAZI PHARMA LTD

New Owner After Registration #1
98
CY

Legal Representation

Attorney
William S. Fultz

USPTO Deadlines

Next Deadline
1565 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-10-31)
Due Date
October 31, 2029
Grace Period Ends
April 30, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description Documents
Aug 9, 2024 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Feb 26, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 2, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Feb 2, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jan 31, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Nov 12, 2023 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Oct 31, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 31, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 25, 2023 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Oct 25, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Aug 20, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Aug 15, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 15, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 2, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Aug 2, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jul 26, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 7, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 30, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 30, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 30, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 19, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 28, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Mar 28, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Feb 1, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jan 31, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 30, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 27, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 23, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 19, 2022 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in dermatology; injectable preparations for medical and pharmaceutical purposes, namely, injectable dermal fillers; pharmaceutical preparations made from hyaluronic acid for use in dermatology; pharmaceutical preparations made from lidocaine for use in dermatology; injectable preparations made from lidocaine for use as local anesthetics; injectable preparations made from hyaluronic acid for use in dermatology; filled syringes sold filled with pharmaceutical preparations made from lidocaine and hyaluronic acid for medical purposes; pre-filled syringes sold filled with pharmaceutical preparations made from lidocaine and hyaluronic acid for medical purposes

Additional Information

Design Mark
The mark consists of the stylized wording "FILLDERM" to the right of a circular design comprised of smaller circles and asymmetrical cell shapes, all in teal.
Color Claim
The color(s) teal is/are claimed as a feature of the mark.

Classification

International Classes
005